20.14.Z - Manufacture of other organic basic chemicals
20.53.Z - Manufacture of essential oils
20.59.Z - Manufacture of other chemical products not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical substances
38.22.Z - Hazardous waste processing and neutralizing
46.46.Z - Wholesale of pharmaceutical goods
46.75.Z - Wholesale of chemical products
49.41.Z - Freight transport by road
71.20.B - Other technical testing and analysis
72.19.Z - Other research and experimental development on natural sciences and engineering
2020 | 2021 | 2022 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | 28,4 | -10,3 | -50,2 | -387,5 |
EBITDA | 28,4 | -10,3 | -50,2 | -387,5 |
Short time liabilities | 88 | 0 | 18,2 | -∞ |
Equity capital | 177 | 166,7 | 116,5 | -30,1 |
Operating profit (EBIT) | 28,4 | -10,3 | -50,2 | -387,5 |
Assets | 265 | 166,7 | 134,6 | -19,2 |
Net profit (loss) | 25,8 | -10,3 | -50,2 | -387,5 |
Cash | 225,2 | 0,4 | 0 | -100 |
Net income from sale | 132,7 | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 88 | 0 | 18,2 | -∞ |
Working assets | 265 | 166,7 | 134,6 | -19,2 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 14,6 | -6,2 | -43,1 | -36,9 |
Equity capital to total assets | 66,8 | 100 | 86,5 | -13,5 |
Gross profit margin | 21,4 | -33,5 | ||
EBITDA Margin | 21,4 | -33,5 | ||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 242 | 0 | 2 147 483 648 | 2 147 483 648 |
Current financial liquidity indicator | 3.0107100009918213 | 7.416288375854492 | 4,4 | |
Net dept to EBITDA | -7.935236930847168 | 0.0403188019990921 | 0 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane